FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety.

Bibliographic Details
Corporate Author:	United States. Department of Health and Human Services. Office of Inspector General (Author)
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2013.
Subjects:	Medicare. United States. > Food and Drug Administration > Auditing. Drugs > Risk assessment > United States > Evaluation. Drugs > United States > Safety measures > Evaluation.
Online Access:	https://purl.fdlp.gov/GPO/gpo68938 http://purl.fdlp.gov/GPO/gpo68938

Description
Item Description:	Title from title screen (viewed June 13, 2016). "February 2013." "OEI-04-11-00510."
Physical Description:	1 online resource (34 pages) : illustrations
Bibliography:	Includes bibliographical references.